15th April 2024 Blis / VMS
The timing of several major customer orders, increased B2B sales and some R&D underspend will provide a boost to Blis Technologies’ annual results for the year to 31 March 2024.
A strong third quarter has prompted Blis Technology to flag a forecasted return to full-year profitability.
The ex-CEO of The Better Health Company Group, Scott Johnson, will take the reins at the probiotics firm.
Blis Technologies delivered revenue growth of 18% and a break-even EBITDA result for the first quarter ending 30 June 2023.
Probiotics manufacturer Blis Technologies has delivered revenue of $10.2m, 14% growth on the prior year, with an EBITDA loss of $0.6m and a net deficit of $1.4m.
Dunedin probiotics company Blis Technologies has upgraded its revenue and earnings guidance for the financial year ended 31 March 2023.
Dunedin probiotics company Blis Technologies delivered revenue growth of 24% and a positive EBITDA result for the third quarter ending 31 Dec 2022.
Dunedin probiotics company Blis Technology has delivered a 10% increase in revenue to $4.3m in the six months to 30 September, but remained in the red.
Commercial director Frank Spiewack is no longer part of the company’s senior leadership team and will report to Walker, who takes the newly created role of chief revenue officer.
A 2021 tie-up with Probi provides a blueprint for the Dunedin probiotics company, prompting it to move away from direct-to-consumer sales.
Probiotics company Blis Technologies has slipped into the red posting an EBITDA loss of $2.1m – slightly ahead of guidance – on the back of $9m of revenue in the year to March 2022.
T&G Global says its group profit for the 2021 financial year is now forecast to be between $12.5m – $14.5m, up from its October guidance of $4m – $10m.
Blis Technologies marketing and e-commerce director, Laura Grant, is leaving the Dunedin headquartered probiotics firm she joined just six months ago.
Probiotics firm Blis Technologies has reported an interim loss of $1.80m for the six months to September 2021, down 268% on the $1.07m profit it made for the same period last year.
Blis Technologies’ chief marketing officer, Julie Curphey, has resigned from her role effective 29 October 2021.
Dunedin probiotics firm Blis Technologies has been given access to a raft of new global opportunities after selling a 13% stake to form a strategic partnership with Swedish giant Probi.
NZX-listed probiotics firm Blis Technologies said its strategic partnership with Swedish giant Probi will open up “significant growth opportunities” and see the New Zealand firm’s products delivered to new markets around the globe.
Blis delivers earnings of $1m – at the lower end of its guidance – in its annual results.
Laura Grant will join Blis’s executive team in the role of e-commerce director on 24 May 2021.
New approach in Australia means ramping up online sales and securing a new distributor.
Blis Technologies says it has secured approval from the Food Safety and Standards Authority of India for its BLIS M18™ and BLIS K12™ probiotic strains to be used in health supplements.
© 2024 Business Media Network Ltd
Website by Webstudio